PharmaEssentia Corporation PharmaEssentia Corporation

PharmaEssentia Corporation

6446

Peringkat dalam Saham #1442
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Harga Saham
$36.89
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$15.25B
Perubahan (1 hari)
-1.28%
Perubahan (1 tahun)
142.49%
Negara
TW
Perdagangan PharmaEssentia Corporation (6446)

Kategori

Healthcare
Riwayat pemecahan saham untuk PharmaEssentia Corporation (6446)
Saham PharmaEssentia Corporation (simbol: 6446) telah mengalami total 2 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Jul 09, 2026.
Satu lembar saham 6446 yang dibeli sebelum Sep 11, 2025 sekarang setara dengan 1.229881 lembar saham 6446.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
2026-07-09 1109:1000 x1.109 x1.229881
2025-09-11 1109:1000 x1.109 x1.109
Pemecahan saham untuk perusahaan sejenis atau pesaing